Exploring Longevity Interventions

Kara discusses the potential benefits of lower doses of rapamycin and metformin for healthspan promotion, emphasizing the need for careful consideration in their use. She highlights ongoing research into metformin's effects beyond diabetes and expresses caution regarding the self-experimentation trends surrounding gene editing technologies like CRISPR. The conversation touches on groundbreaking studies that have successfully reversed aging in cells, showcasing the exciting yet daunting frontier of longevity science.